This article was originally published in The Tan Sheet
San Francisco grand jury returns 42-count indictment against four defendants associated with distributing anabolic steroids including tetrahydragestrinone (THG), Justice Department announces Feb. 12. Case was brought by FDA Commissioner Mark McClellan, MD/PhD, Attorney General John Ashcroft, IRS Commissioner Mark Everson and U.S. Attorney Kevin Ryan. Charges include conspiracy to possess with intent to distribute anabolic steroids, violating the FD&C Act by misbranding THG and failing to correctly label the drug being sold. The indictment also alleges six separate occasions in which steroids actually were distributed to athletes. The four defendants are Bay Area Lab Cooperative President Victor Conte and VP James Valente, personal trainer Greg Anderson and track coach Remi Korchemny. THG previously was marketed as a dietary supplement, but was banned by FDA in October (1"The Tan Sheet" Nov. 3, 2003, p. 14)...
You may also be interested in...
FDA's ban of tetrahydrogestrinone (THG) represents another black eye for sports supplements, coinciding with the highly publicized debate over the safety of ephedra-containing products
The entry of India’s state-owned Indian Immunologicals and partner Griffith University in the COVID-19 vaccine race could potentially disrupt pricing dynamics. The alliance is developing a live-attenuated, single dose vaccine, which it hopes will be ready for launch in 18-24 months.
Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.